+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Early Phase 1
Age: 12Years +
All Genders
ID07474883

Comparing Topical 0.5% Timolol Eye Drops and Intense Pulsed Light Therapy for Treating Post-Inflammatory Erythema After Acne Vulgaris

Led by Pham Ngoc Thach University of Medicine · Updated on 2026-04-01

60

Participants Needed

1

Research Sites

8 weeks

Total Duration

AI-Summary

What This Trial Is About

This research aims to evaluate the effectiveness and safety of topical 0.5% timolol eye drops in treating post-inflammatory erythema PIE, a common red skin condition that follows acne vulgaris. The study compares timolols effects with those of intense pulsed light IPL therapy, which is currently used but can be costly and require special equipment. The goal is to find a more affordable and accessible treatment option for managing PIE after acne. Participants will be randomly assigned to one of two groups. One group will apply timolol 0.5% ophthalmic solution twice daily to the affected skin areas for four weeks. The other group will receive a single session of IPL therapy targeting the erythema lesions at the start of the treatment period. Both groups will have their skin condition monitored and evaluated throughout the study. During the study, researchers will assess the severity of erythema using a clinical scale and count the number of lesions at baseline, day 14, and day 28. They will also monitor participants for any local or systemic side effects. Patient satisfaction with the aesthetic results will be measured at day 28. The study is expected to provide detailed information on how each treatment affects post-inflammatory erythema over the one-month period.

CONDITIONS

Brief Title

Efficacy of 0.5% Topical Timolol Eye Drops in the Treatment of Post-Inflammatory Erythema Following Acne Vulgaris

Research Team

P

Pham Duc Vu

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here